Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Top Cited Papers
Open Access
- 14 July 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 8, 461
Abstract
Fibrosis occurs when there is an imbalance in extracellular matrix (ECM) deposition and degradation. Excessive ECM deposition results in scarring and thickening of the affected tissue, and interferes with tissue and organ homeostasis – mimicking an exaggerated “wound healing” response. Many transforming growth factor-β (TGF-β) ligands are potent drivers of ECM deposition, and additionally, have a natural affinity for the ECM, creating a concentrated pool of pro-fibrotic factors at the site of injury. Consequently, TGF-β ligands are upregulated in many human fibrotic conditions and, as such, are attractive targets for fibrosis therapy. Here, we will discuss the contribution of TGF-β proteins in the pathogenesis of fibrosis, and promising anti-fibrotic approaches that target TGF-β ligands.Keywords
Funding Information
- National Health and Medical Research Council (1078907, Victorian Cancer Agency - Early Career Seed Grant)
This publication has 126 references indexed in Scilit:
- Interleukin-6, its role in fibrosing conditionsCytokine & Growth Factor Reviews, 2012
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- Loss of Endogenous Bone Morphogenetic Protein-6 Aggravates Renal FibrosisThe American Journal of Pathology, 2011
- Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding ActivityJournal of Biological Chemistry, 2010
- Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4Journal of Clinical Investigation, 2010
- Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healingEMBO Reports, 2010
- Effects of myostatin deletion in aging miceAging Cell, 2009
- Myostatin Directly Regulates Skeletal Muscle FibrosisJournal of Biological Chemistry, 2008
- Myofibroblast contraction activates latent TGF-β1 from the extracellular matrixJournal of Cell Biology, 2007
- Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosisJournal of Clinical Pathology, 2006